Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
about
Tumour infiltrating lymphocytes correlate with improved survival in patients with esophageal squamous cell carcinoma.The combination of PD-L1 expression and decreased tumor-infiltrating lymphocytes is associated with a poor prognosis in triple-negative breast cancer.Clinical Validity and Utility of Tumor-Infiltrating Lymphocytes in Routine Clinical Practice for Breast Cancer Patients: Current and Future Directions.Reliability of tumor-infiltrating lymphocyte and tertiary lymphoid structure assessment in human breast cancer.Prognostic Value of Tumor-Infiltrating Lymphocyte Density Assessed Using a Standardized Method Based on Molecular Subtypes and Adjuvant Chemotherapy in Invasive Breast Cancer.Tumour-infiltrating lymphocytes (TILs)-related genomic signature predicts chemotherapy response in breast cancer.Tumor-infiltrating lymphocytes affect the efficacy of trastuzumab-based treatment in human epidermal growth factor receptor 2-positive breast cancer.Tumor-infiltrating Lymphocytes Predict the Chemotherapeutic Outcomes in Patients with Stage IV Colorectal Cancer.Standardized assessment of tumor-infiltrating lymphocytes in breast cancer: an evaluation of inter-observer agreement between pathologists.Composite analysis of immunological and metabolic markers defines novel subtypes of triple negative breast cancer.A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
P2860
Q37713070-AEE58FC9-626D-4CC0-9F66-642A110F663EQ37716582-93C0F6D1-7319-4A23-AA29-56998B41F84DQ38639746-36BFC279-0182-4E86-A467-E0FB512D8C4AQ38670277-5319E539-FDF0-4B66-903A-C05D7E074E35Q47734351-0537A4D4-5173-40BC-95B9-34D9FE42EB1BQ47988029-FC736F15-2160-40A1-A5D1-942C1896BAA3Q48219547-AC2EF7F3-6675-40DB-861C-AF1FA378AFF9Q48529729-89D06791-305D-40BC-8643-CC0C66B953E3Q48550627-8EA9BEBE-760E-4B39-9AC1-2D29D60154EAQ49564212-567A695B-EC77-480B-B0B6-31C23457D975Q52561263-7769583F-E7B2-4649-8328-17D0CB9751A8Q55091056-15FA01FB-8801-4D31-B181-9075E303AEA9Q58781862-5AC89478-C043-4C9F-ADBC-027D6757060F
P2860
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Interobserver Agreement Betwee ...... ernational TILs Working Group.
@en
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes
@nl
type
label
Interobserver Agreement Betwee ...... ernational TILs Working Group.
@en
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes
@nl
prefLabel
Interobserver Agreement Betwee ...... ernational TILs Working Group.
@en
Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes
@nl
P2093
P2860
P50
P1476
Interobserver Agreement Betwee ...... ternational TILs Working Group
@en
P2093
Aysegul Sahin
Coya Tapia
Elizabeth A Mittendorf
Genvieve R Lyons
Roland Bassett
Shannon K Swisher
Xiuhong Wang
P2860
P2888
P304
P356
10.1245/S10434-016-5173-8
P577
2016-03-10T00:00:00Z
P6179
1024468668